Can the safe harbor of 35 U.S.C. section 271(e)(1) shelter pioneer drug manufacturers?
Brinckerhoff
C C
CC
D017277:Drug Approval; D016527:Drug Costs; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004465:Economic Competition / Q000331:legislation & jurisprudence; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D014481:United States